View Older Stories View More Recent Stories
-
Stock Market Overvalued: Where Should Investors Turn? Michael Eisenga provides insight.
-
Historic Shift: Passkeys Set to Become Leading Authentication Method by 2027, New Survey Reveals
-
February 2025: New Business Volumes Rebound
-
Morning Bid: The confidence game
-
SMITHFIELD FOODS REPORTS STRONG FOURTH QUARTER AND FISCAL YEAR 2024 RESULTS LED BY PACKAGED MEATS SEGMENT
-
Barclays Downgrades Volvo AB (VOLVB:SS) (VLVLY) to Underweight
-
Dropbox faces pressure from activist investor to end co-founder's control, WSJ reports
-
Satellogic Reports 2024 Financial Results and Business Update
-
Spineway : Consolidated 2024 annual results - Operating income close to breakeven
-
Trump's port fees on Chinese ships threaten US maritime industry, say executives
-
Integrated Financial Technologies Launches "Smartsourcing-as-a-Service" Channel Program
-
1 in 4 Companies Say AI Skills Protect Workers From Layoffs
-
Morning Bid: Tariff exclusion hopes prop up markets
-
UK services firms provide relief to Reeves before tough budget update
-
Trump’s regulatory freeze throws US fishing industry into chaos
-
U.S. homeland department targets oversight in government cuts
-
Volta Finance Limited - Net Asset Value(s) as at 28 February 2025
-
ResumeTemplates.com Survey: 1 in 5 U.S. Workers Fear Layoffs in 2025
-
Analysis-German fiscal bonanza no quick fix as red tape, labour snags weigh
-
Voters frustrated with Democrats' response as Trump runs roughshod over Congress
-
White House begins review of federal agency plans for second round of mass layoffs, sources say
-
Senti Bio Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Pipeline and Corporate Highlights
-
Enterprises to Boost AI and Data Analytics Skills in Global Capability Centers: ISG Study
-
TD Cowen on Enova International (ENVA): 'Operating Environment Remains Strong Despite Macro Volatility'
-
US labor market holding steady, but job opportunities dwindling
-
Elevation Oncology (ELEV) to Discontinue Development of EO-3021
-
Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options
-
Adaptimmune Provides Q4 and Full Year 2024 Business Update
-
NeueHealth Reports Fourth Quarter and Full Year 2024 Results
-
VA shake-up disrupts mental health services for some US veterans
-
New Zealand Defence Force looks to cut some civilian roles
-
Australia employment posts surprise fall in February but jobless rate still low
-
Trump to sign order to shut down Department of Education, White House says
-
ADVISORY: Putting workers first in the election – United Steelworkers and NDP Leader Jagmeet Singh
-
Bakkt Reports Fourth Quarter and Full Year 2024 Results
-
Precigen Reports Full Year 2024 Financial Results and Business Updates
-
Auto Industry Calls for British Columbia to Pause and Review Its EV Sales Mandate
-
Deutsche Bank plans to cut 2,000 jobs with 'signficant' branch reduction
-
Morgan Stanley to lay off about 2,000 employees to trim costs, source says
-
ADVISORY: Workers need swift action in the face of layoffs and uncertainty
-
Siemens to cut 8% of jobs at struggling factory automation business
-
Former HR Executive Releases New Book to Help Job Seekers Navigate Career Setbacks and Secure New Opportunities
-
US import prices increase solidly in February
-
TC Biopharm (TCBP) Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
-
TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
-
Morning Bid: US stocks stabilise as Europe keeps surging
-
Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Concerns about AI and social media grow among journalists ahead of Federal Election, survey finds
-
German premium carmakers weigh price, production shifts to soften tariff blow
-
Operation HOPE CEO John Hope Bryant Leads CNBC Executive Panel on AI and Workforce Transformation in Singapore
